15145918|t|Differential modulation by estrogen of alpha2-adrenergic and I1-imidazoline receptor-mediated hypotension in female rats.
15145918|a|We have recently shown that estrogen negatively modulates the hypotensive effect of clonidine (mixed alpha2-/I1-receptor agonist) in female rats and implicates the cardiovascular autonomic control in this interaction. The present study investigated whether this effect of estrogen involves interaction with alpha2- and/or I1-receptors. Changes evoked by a single intraperitoneal injection of rilmenidine (600 microg/kg) or alpha-methyldopa (100 mg/kg), selective I1- and alpha2-receptor agonists, respectively, in blood pressure, hemodynamic variability, and locomotor activity were assessed in radiotelemetered sham-operated and ovariectomized (Ovx) Sprague-Dawley female rats with or without 12-wk estrogen replacement. Three time domain indexes of hemodynamic variability were employed: the standard deviation of mean arterial pressure as a measure of blood pressure variability and the standard deviation of beat-to-beat intervals (SDRR) and the root mean square of successive differences in R-wave-to-R-wave intervals as measures of heart rate variability. In sham-operated rats, rilmenidine or alpha-methyldopa elicited similar hypotension that lasted at least 5 h and was associated with reductions in standard deviation of mean arterial pressure. SDRR was reduced only by alpha-methyldopa. Ovx significantly enhanced the hypotensive response to alpha-methyldopa, in contrast to no effect on rilmenidine hypotension. The enhanced alpha-methyldopa hypotension in Ovx rats was paralleled with further reduction in SDRR and a reduced locomotor activity. Estrogen replacement (17beta-estradiol subcutaneous pellet, 14.2 microg/day, 12 wk) of Ovx rats restored the hemodynamic and locomotor effects of alpha-methyldopa to sham-operated levels. These findings suggest that estrogen downregulates alpha2- but not I1-receptor-mediated hypotension and highlight a role for the cardiac autonomic control in alpha-methyldopa-estrogen interaction.
15145918	27	35	estrogen	ChemicalEntity	D004967
15145918	39	84	alpha2-adrenergic and I1-imidazoline receptor	GeneOrGeneProduct	25083,64652
15145918	94	105	hypotension	DiseaseOrPhenotypicFeature	D007022
15145918	116	120	rats	OrganismTaxon	10116
15145918	150	158	estrogen	ChemicalEntity	D004967
15145918	184	195	hypotensive	DiseaseOrPhenotypicFeature	D007022
15145918	206	215	clonidine	ChemicalEntity	D003000
15145918	223	242	alpha2-/I1-receptor	GeneOrGeneProduct	25083,64652
15145918	262	266	rats	OrganismTaxon	10116
15145918	394	402	estrogen	ChemicalEntity	D004967
15145918	429	456	alpha2- and/or I1-receptors	GeneOrGeneProduct	25083,64652
15145918	514	525	rilmenidine	ChemicalEntity	C032302
15145918	545	561	alpha-methyldopa	ChemicalEntity	D008750
15145918	585	608	I1- and alpha2-receptor	GeneOrGeneProduct	25083,64652
15145918	795	799	rats	OrganismTaxon	10116
15145918	822	830	estrogen	ChemicalEntity	D004967
15145918	1201	1205	rats	OrganismTaxon	10116
15145918	1207	1218	rilmenidine	ChemicalEntity	C032302
15145918	1222	1238	alpha-methyldopa	ChemicalEntity	D008750
15145918	1256	1267	hypotension	DiseaseOrPhenotypicFeature	D007022
15145918	1402	1418	alpha-methyldopa	ChemicalEntity	D008750
15145918	1451	1462	hypotensive	DiseaseOrPhenotypicFeature	D007022
15145918	1475	1491	alpha-methyldopa	ChemicalEntity	D008750
15145918	1521	1532	rilmenidine	ChemicalEntity	C032302
15145918	1533	1544	hypotension	DiseaseOrPhenotypicFeature	D007022
15145918	1559	1575	alpha-methyldopa	ChemicalEntity	D008750
15145918	1576	1587	hypotension	DiseaseOrPhenotypicFeature	D007022
15145918	1595	1599	rats	OrganismTaxon	10116
15145918	1650	1678	a reduced locomotor activity	DiseaseOrPhenotypicFeature	D001523
15145918	1702	1718	17beta-estradiol	ChemicalEntity	D004958
15145918	1771	1775	rats	OrganismTaxon	10116
15145918	1826	1842	alpha-methyldopa	ChemicalEntity	D008750
15145918	1896	1904	estrogen	ChemicalEntity	D004967
15145918	1919	1946	alpha2- but not I1-receptor	GeneOrGeneProduct	25083
15145918	1956	1967	hypotension	DiseaseOrPhenotypicFeature	D007022
15145918	2026	2042	alpha-methyldopa	ChemicalEntity	D008750
15145918	2043	2051	estrogen	ChemicalEntity	D004967
15145918	Positive_Correlation	D003000	64652	No
15145918	Positive_Correlation	D003000	D007022	No
15145918	Positive_Correlation	D003000	25083	No
15145918	Negative_Correlation	D004967	D003000	No
15145918	Association	D004967	64652	Novel
15145918	Negative_Correlation	D004967	D007022	No
15145918	Negative_Correlation	D004967	25083	Novel
15145918	Positive_Correlation	C032302	64652	No
15145918	Positive_Correlation	C032302	D007022	Novel
15145918	Positive_Correlation	C032302	25083	No
15145918	Association	D008750	D004967	Novel
15145918	Positive_Correlation	D008750	64652	No
15145918	Positive_Correlation	D008750	D007022	Novel
15145918	Positive_Correlation	D008750	25083	No
15145918	Association	64652	D007022	No
15145918	Association	25083	D007022	No